Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1969 1
1974 2
1975 1
1992 5
1993 7
1994 3
1995 1
1996 4
1997 5
1998 3
1999 2
2000 3
2001 2
2003 1
2005 3
2006 2
2007 3
2008 2
2010 6
2011 6
2012 1
2013 3
2014 1
2015 1
2016 3
2017 2
2018 5
2020 3
2021 3
2022 4
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for nat promm
Your search for Nat Promma retrieved no results
Molecular mechanisms underlying nucleotide repeat expansion disorders.
Malik I, Kelley CP, Wang ET, Todd PK. Malik I, et al. Nat Rev Mol Cell Biol. 2021 Sep;22(9):589-607. doi: 10.1038/s41580-021-00382-6. Epub 2021 Jun 17. Nat Rev Mol Cell Biol. 2021. PMID: 34140671 Free PMC article. Review.
Expansion of a subset of these repeat tracts underlies over fifty human disorders, including common genetic causes of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (C9orf72), polyglutamine-associated ataxias and Huntington disease, myotonic dystrophy
Expansion of a subset of these repeat tracts underlies over fifty human disorders, including common genetic causes of amyotrophic lateral sc …
MYTHO is a novel regulator of skeletal muscle autophagy and integrity.
Leduc-Gaudet JP, Franco-Romero A, Cefis M, Moamer A, Broering FE, Milan G, Sartori R, Chaffer TJ, Dulac M, Marcangeli V, Mayaki D, Huck L, Shams A, Morais JA, Duchesne E, Lochmuller H, Sandri M, Hussain SNA, Gouspillou G. Leduc-Gaudet JP, et al. Nat Commun. 2023 Mar 2;14(1):1199. doi: 10.1038/s41467-023-36817-1. Nat Commun. 2023. PMID: 36864049 Free PMC article.
Inhibition of the mTORC1 signaling pathway in mice using rapamycin treatment attenuates the myopathic phenotype triggered by MYTHO knockdown. Skeletal muscles from human patients diagnosed with myotonic dystrophy type 1 (DM1) display reduced Mytho expression, activa …
Inhibition of the mTORC1 signaling pathway in mice using rapamycin treatment attenuates the myopathic phenotype triggered by MYTHO knockdown …
Clearance of defective muscle stem cells by senolytics restores myogenesis in myotonic dystrophy type 1.
Conte TC, Duran-Bishop G, Orfi Z, Mokhtari I, Deprez A, Côté I, Molina T, Kim TY, Tellier L, Roussel MP, Maggiorani D, Benabdallah B, Leclerc S, Feulner L, Pellerito O, Mathieu J, Andelfinger G, Gagnon C, Beauséjour C, McGraw S, Duchesne E, Dumont NA. Conte TC, et al. Nat Commun. 2023 Jul 19;14(1):4033. doi: 10.1038/s41467-023-39663-3. Nat Commun. 2023. PMID: 37468473 Free PMC article.
Muscle stem cells, the engine of muscle repair, are affected in myotonic dystrophy type 1 (DM1); however, the underlying molecular mechanism and the impact on the disease severity are still elusive. ...
Muscle stem cells, the engine of muscle repair, are affected in myotonic dystrophy type 1 (DM1); however, the underlying molec …
Anticipating anticipation.
Korneluk RG, Narang MA. Korneluk RG, et al. Nat Genet. 1997 Feb;15(2):119-20. doi: 10.1038/ng0297-119. Nat Genet. 1997. PMID: 9020832 No abstract available.
Muscleblind-like proteins use modular domains to localize RNAs by riding kinesins and docking to membranes.
Hildebrandt RP, Moss KR, Janusz-Kaminska A, Knudson LA, Denes LT, Saxena T, Boggupalli DP, Li Z, Lin K, Bassell GJ, Wang ET. Hildebrandt RP, et al. Nat Commun. 2023 Jun 9;14(1):3427. doi: 10.1038/s41467-023-38923-6. Nat Commun. 2023. PMID: 37296096 Free PMC article.
RNA binding proteins (RBPs) act as critical facilitators of spatially regulated gene expression. Muscleblind-like (MBNL) proteins, implicated in myotonic dystrophy and cancer, localize RNAs to myoblast membranes and neurites through unknown mechanisms. ...
RNA binding proteins (RBPs) act as critical facilitators of spatially regulated gene expression. Muscleblind-like (MBNL) proteins, implicate …
Restoring myogenesis in myotonic dystrophy.
Wood H. Wood H. Nat Rev Neurol. 2023 Sep;19(9):508. doi: 10.1038/s41582-023-00862-7. Nat Rev Neurol. 2023. PMID: 37553392 No abstract available.
Moving with Muscleblind.
de Andrade GR, Jansen RP. de Andrade GR, et al. Nat Cell Biol. 2005 Dec;7(12):1155-6. doi: 10.1038/ncb1205-1055. Nat Cell Biol. 2005. PMID: 16319965 No abstract available.
Reversal of fortune.
Timchenko L. Timchenko L. Nat Genet. 2006 Sep;38(9):976-7. doi: 10.1038/ng0906-976. Nat Genet. 2006. PMID: 16941004 No abstract available.
Chronic endoplasmic reticulum stress in myotonic dystrophy type 2 promotes autoimmunity via mitochondrial DNA release.
Rösing S, Ullrich F, Meisterfeld S, Schmidt F, Mlitzko L, Croon M, Nattrass RG, Eberl N, Mahlberg J, Schlee M, Wieland A, Simon P, Hilbig D, Reuner U, Rapp A, Bremser J, Mirtschink P, Drukewitz S, Zillinger T, Beissert S, Paeschke K, Hartmann G, Trifunovic A, Bartok E, Günther C. Rösing S, et al. Nat Commun. 2024 Feb 20;15(1):1534. doi: 10.1038/s41467-024-45535-1. Nat Commun. 2024. PMID: 38378748 Free PMC article.
Myotonic dystrophy type 2 (DM2) is a tetranucleotide CCTG repeat expansion disease associated with an increased prevalence of autoimmunity. ...
Myotonic dystrophy type 2 (DM2) is a tetranucleotide CCTG repeat expansion disease associated with an increased prevalence of
Targeting RNA to treat neuromuscular disease.
Muntoni F, Wood MJ. Muntoni F, et al. Nat Rev Drug Discov. 2011 Aug 1;10(8):621-37. doi: 10.1038/nrd3459. Nat Rev Drug Discov. 2011. PMID: 21804598 Review.
The development of effective therapies for neuromuscular disorders such as Duchenne muscular dystrophy (DMD) is hampered by considerable challenges: skeletal muscle is the most abundant tissue in the body, and many neuromuscular disorders are multisystemic conditions. ...
The development of effective therapies for neuromuscular disorders such as Duchenne muscular dystrophy (DMD) is hampered by considera …
94 results